New York, NY (PRWEB) February 07, 2013
On February 7, 2013, Voices Against Brain Cancer (VABC) responds to the first Cam Neely Award for Courage, which was given to Nick Claudio, an inspiring 12-year-old boy who is battling cancer.
According to CBS News, Nick Claudio learned he had brain cancer after he went unexpectedly blind at just 10 years old. Since his diagnosis, Nick has bravely battled the disease for two years. “The best way to look at it is positively. Because if you’re looking at it negatively, you won’t get anywhere,” said the 12-year-old in the recent article.
During the last two years, Nick has learned how to ski, how to read Braille, and has been an extremely funny and courageous young man. The bravery he has shown is the reason why Nick will receive the first ever Cam Neely Award for Courage in March 2013.
The award is named after the NHL hall of famer Cam Neely, who played for the Boston Bruins and founded the Cam Neely Foundation for Cancer Care. The award aims to honor those who have bravely battled cancer or other serious diseases as well as caregivers who have dedicated themselves to caring for patients.
“Showing brain cancer patients support through awards like the Cam Neely Award for Courage is a great way to keep their spirits high. A positive outlook can really make all the difference in their fight,” said Michael Klipper, VABC Chairman. “Nick is obviously a special kid and he deserves recognition for keeping a positive attitude during such a negative time.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.